Cognitive Behavioral Therapy App for Cancer Pain
(STAMP+CBT Trial)
DA
Overseen byDesiree Azizoddin, PsyD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of Oklahoma
No Placebo Group
Approved in 4 Jurisdictions
Trial Summary
What is the purpose of this trial?
This trial tests the STAMP+CBT app, a smartphone tool for advanced cancer patients to manage pain and mood. It tracks health metrics and provides personalized advice and educational content to improve pain management.
Research Team
DA
Desiree Azizoddin, PsyD
Principal Investigator
Stephenson Cancer Center
Eligibility Criteria
This trial is for adults over 18 with advanced cancer experiencing chronic pain (pain score >4) and using opioids to manage it. They must be undergoing treatment or receiving supportive care, not in remission, hospice, or hospitalized. Excludes those with cognitive impairments affecting participation, non-English speakers, recent surgery patients, and individuals under opioid risk mitigation programs.Inclusion Criteria
I am currently prescribed opioids for my cancer pain.
I have an advanced cancer diagnosis and am currently receiving treatment or supportive care.
My cancer or its treatment causes me significant pain.
See 2 more
Exclusion Criteria
You are currently receiving hospice care.
I am an adult capable of giving consent, not pregnant, and not incarcerated.
My main pain is from a surgery I had within the last 2 weeks.
See 5 more
Treatment Details
Interventions
- Cognitive Behavioral Therapy (Behavioral Intervention)
Trial OverviewThe study tests a new smartphone app called STAMP+CBT designed to help track pain levels, mood changes, opioid use and side effects while providing personalized education and self-management tips for managing cancer-related pain.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: STAMP+CBT appExperimental Treatment1 Intervention
This app will allow the patient to access daily surveys designed to assess pain, stress, mood, and related symptoms.
Based on patient-reported symptoms, this app will disseminate tailored education to manage the symptoms.
Cognitive Behavioral Therapy is already approved in Canada for the following indications:
Approved in Canada as Cognitive Behavioral Therapy for:
- Anxiety disorders
- Depressive disorders
- Eating disorders
- Post-traumatic stress disorder (PTSD)
- Obsessive-compulsive disorder (OCD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Oklahoma
Lead Sponsor
Trials
484
Recruited
95,900+
National Cancer Institute (NCI)
Collaborator
Trials
14,080
Recruited
41,180,000+